Skip to main content
Skip to main content
THRA logo

Therma-Med, Inc. (THRA)

$0.00 +$0.00 (+0.00%) |CouncilHOLD · 50 · B
Bottom line: HOLD — our Council read (50/100) and AI Score (50/100) broadly agree.
MCap: 392K| Vol: 500.0K| 52-wk range: $0.00 – $0.00
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Therma-Med, Inc. (THRA) trades at $0.00 with AI Score 50/100 (Grade B). Therma-Med Inc. is a Basic Materials company focused on the acquisition, exploration, and development of precious and base metal mineral properties in Canada. Market cap: $392,118, Sector: Basic materials.

Price live · AI analysis from Jun 15, 2026
Therma-Med Inc. is a Basic Materials company focused on the acquisition, exploration, and development of precious and base metal mineral properties in Canada. The company primarily targets silver, zinc, and lead deposits within the Slocan Mining Division of British Columbia.

Analyst Coverage for THRA: THRA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates THRA against Basic Materials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 50/100 · B

THRA: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Therma-Med, Inc. (THRA) Materials & Commodity Exposure

CEOJoshua Suarez
HeadquartersBeverly Hills, US
IPO Year2003

Therma-Med Inc. is a Beverly Hills-based mineral exploration company established in 1988, specializing in the acquisition and development of silver, zinc, and lead properties within Canada's Slocan Mining Division. Operating in the Basic Materials sector, it focuses on identifying and advancing precious and base metal resources in British Columbia.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for THRA?

Therma-Med Inc. (THRA) presents an investment profile centered on its pure-play exposure to precious and base metal exploration in Canada, specifically targeting silver, zinc, and lead within British Columbia's Slocan Mining Division. With a market capitalization of 392K and a high Beta of 9.96, the company exhibits characteristics typical of early-stage exploration ventures, implying significant sensitivity to market movements and commodity price fluctuations. The core value driver for THRA is the potential for successful mineral discoveries that could lead to the definition of substantial resources. Growth catalysts include positive drilling results, updated resource estimates, and sustained or increasing global demand for silver, zinc, and lead, which could enhance the value of its mineral claims. For instance, a significant discovery could drastically re-rate the company's valuation. Conversely, the investment carries inherent risks, including the speculative nature of exploration, dependence on commodity price cycles, and the absence of a dividend yield. The company's long operating history since 1988 suggests experience in the sector, but its current market valuation reflects the early-stage nature of its current projects. Investors would primarily be exposed to the upside potential of successful exploration and favorable commodity market dynamics.

Based on FMP financials and quantitative analysis

THRA Key Highlights

  • Market Capitalization of 392K, reflecting its early-stage exploration profile.
  • Beta of 9.96, indicating high volatility and significant sensitivity to market movements.
  • No dividend yield, consistent with a growth-focused mineral exploration company.
  • Primary focus on silver, zinc, and lead exploration within the Slocan Mining Division, British Columbia, Canada.
  • Incorporated in 1988, demonstrating a long-standing presence in the mineral exploration sector.

Who Are THRA's Competitors?

THRA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
MTA Metalla Royalty & Streaming Ltd. acquires and manages precious metal royalties and streams, focusing on gold and silver. The company $7.48 -2.09% $698.95M 68
EMPYF Empress Royalty Corp. $0.61 -9.31% $80.81M 66
ARIS Aris Mining Corporation $15.89 -0.69% $3.28B 65
BVN Compañía de Minas Buenaventura S.A.A. is involved in the exploration, mining development, processing, and trading of precious and base metals. The company $29.86 +0.49% $7.59B 65
ESGLF EnviroGold Global Limited $0.11 -2.30% $29.81M 50
TPRFF Aris Mining Corporation $2.42 +0.37% $332.02M 50
STRFF Star Royalties Ltd. $0.34 -1.23% $27.00M 50
TSORF Tesoro Gold Ltd $0.74 +3.25% $99.62M 50

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are THRA's Key Strengths?

  • Established corporate entity incorporated in 1988, indicating longevity.
  • Focused exploration strategy on specific precious and base metals (silver, zinc, lead).
  • Operations concentrated in a known mining jurisdiction (Slocan, British Columbia, Canada).
  • Potential for significant value creation from successful mineral discoveries.

What Are THRA's Weaknesses?

  • Market capitalization of 392K, indicating a very small scale.
  • High Beta of 9.96 suggests extreme stock price volatility.
  • No dividend yield, limiting investor returns to capital appreciation.
  • Unknown disclosure status on OTC markets, hindering investor due diligence.

What Could Drive THRA Stock Higher?

  • Positive results from ongoing exploration drilling campaigns on its Slocan properties, potentially leading to resource definition.
  • Publication of an initial or updated mineral resource estimate, compliant with industry standards, for its key projects.
  • Sustained increase in global market prices for silver, zinc, and lead, enhancing the economic viability of potential discoveries.
  • Formation of a strategic partnership or joint venture with a larger mining company to advance project development.
  • Acquisition of new, highly prospective mineral claims that diversify or enhance its exploration portfolio.

What Are the Key Risks for THRA?

  • High inherent geological risk, with no guarantee of discovering economically viable mineral deposits.
  • Significant exposure to the volatility of global commodity prices for silver, zinc, and lead.
  • Challenges in securing adequate funding for ongoing exploration and development activities.
  • Regulatory and environmental risks associated with mineral exploration and potential mining operations in Canada.
  • Lack of transparent financial disclosure and low liquidity due to its OTC Other classification, increasing investment risk.

What Are the Growth Opportunities for THRA?

  • Growth opportunity 1: **Successful Exploration and Resource Definition:** Therma-Med's primary growth opportunity lies in the successful execution of its exploration programs in the Slocan Mining Division of British Columbia. Delineating significant, economically viable resources of silver, zinc, and lead would be a transformative catalyst. The global market for silver is projected to grow, driven by industrial demand in electronics and solar panels, while zinc and lead markets are supported by infrastructure and battery manufacturing. A confirmed resource estimate, compliant with industry standards like NI 43-01, could significantly de-risk the project, attract major mining partners, or lead to a re-rating of the company's valuation. This process typically involves multi-year drilling campaigns and extensive geological studies.
  • Growth opportunity 2: **Favorable Commodity Price Appreciation:** The value of Therma-Med's mineral claims and potential future production is directly tied to the market prices of silver, zinc, and lead. Sustained upward trends in these commodity prices, driven by global economic growth, supply constraints, or increased industrial demand, would enhance the profitability and attractiveness of its projects. For instance, a persistent rise in silver prices above historical averages could make marginal deposits economically viable. Monitoring global economic indicators and supply-demand dynamics for these specific metals is crucial, as price movements can significantly impact project economics and investor sentiment over a 3-5 year horizon.
  • Growth opportunity 3: **Strategic Acquisitions of New Properties:** Expanding its portfolio through the acquisition of additional prospective mineral properties, either within the Slocan Mining Division or other geologically favorable regions in Canada, represents a key growth avenue. Such acquisitions could diversify its exploration risk, increase its overall resource potential, and provide new targets for discovery. Identifying undervalued properties with strong geological indicators for silver, zinc, or lead could provide long-long-term growth. This strategy would typically involve careful due diligence and capital allocation, potentially over a 2-4 year timeframe, to integrate and explore new assets.
  • Growth opportunity 4: **Technological Advancements in Exploration:** The adoption of advanced exploration technologies, such as artificial intelligence for geological data interpretation, remote sensing, or more efficient drilling techniques, could significantly improve Therma-Med's discovery rates and reduce exploration costs. These technologies can help identify hidden deposits more effectively and with less environmental impact. Implementing such innovations could give the company a competitive edge in a capital-intensive industry, potentially accelerating the timeline from prospecting to resource definition and improving the economic viability of projects over a 1-3 year horizon.
  • Growth opportunity 5: **Partnerships and Joint Ventures:** Forming strategic partnerships or joint ventures with larger mining companies could provide Therma-Med with access to greater capital, technical expertise, and operational infrastructure, accelerating the development of its projects. A major partner could fund advanced exploration or even mine development, allowing Therma-Med to retain an interest while mitigating its own capital expenditure requirements. Such collaborations are common in the mining industry for junior explorers seeking to advance projects beyond the early exploration stage. These agreements could materialize following significant discovery milestones, typically within a 2-5 year timeframe.

What Opportunities Does THRA Have?

  • Rising global demand and prices for silver, zinc, and lead.
  • Successful delineation of economically viable mineral resources on its properties.
  • Strategic partnerships or joint ventures with larger mining companies.
  • Acquisition of additional high-potential mineral claims to expand its portfolio.

What Threats Does THRA Face?

  • Inherent risks of mineral exploration, including failure to find economic deposits.
  • Volatility in commodity prices for silver, zinc, and lead.
  • Regulatory changes or environmental restrictions impacting mining activities in Canada.
  • Competition from other junior and major mining companies for capital and resources.

What Are THRA's Competitive Advantages?

  • Proprietary knowledge and geological data pertaining to its specific claims in the Slocan Mining Division.
  • Long-standing presence since 1988, suggesting accumulated experience in mineral exploration.
  • Strategic focus on specific precious and base metals (silver, zinc, lead) in a known mining jurisdiction.
  • Potential for unique or high-grade mineral deposits within its acquired properties.

What Does THRA Do?

Therma-Med Inc., a company incorporated in 1988 and headquartered in Beverly Hills, California, operates within the dynamic Basic Materials sector, with a specialized focus on the Other Precious Metals industry. The company's foundational business model is centered on the strategic acquisition, meticulous exploration, and systematic development of mineral properties primarily located across Canada. This comprehensive approach encompasses the entire lifecycle from initial geological reconnaissance and sampling to advanced geophysical surveys and extensive drilling programs, all aimed at identifying and quantifying economically viable mineral resources. Therma-Med Inc. has strategically concentrated its efforts on mineral claims situated within the Slocan Mining Division of British Columbia, a region historically renowned for its significant mineral endowments. Within this specific division, the company's exploration activities are primarily directed towards properties with the potential to host commercially significant deposits of silver, zinc, and lead. Silver, recognized globally as both a precious metal and an industrial commodity, finds applications in electronics, solar energy, and jewelry, alongside its role as an investment asset. Zinc and lead, vital base metals, are indispensable in numerous industrial processes, including galvanizing steel, battery manufacturing, and construction materials. The company’s operational strategy is designed to progressively de-risk its exploration projects through a phased development approach. This involves advancing promising properties from early-stage prospecting through to resource definition, with the ultimate goal of either bringing them to a production-ready status or delineating substantial mineral resources that can attract larger mining partners, joint venture opportunities, or outright acquisition offers. Its incorporation in 1988 underscores a long-term commitment to the mineral exploration industry, navigating the inherent geological uncertainties and the cyclical volatility of global commodity markets. The Beverly Hills headquarters provides a central hub for corporate governance and investor engagement, while its core operational activities are firmly embedded within the geologically prospective regions of Canada, particularly British Columbia. The success of Therma-Med Inc. is intrinsically linked to the efficacy of its exploration programs and the prevailing market prices of the targeted commodities.

What Products and Services Does THRA Offer?

  • Acquires mineral properties with potential for precious and base metals.
  • Conducts geological exploration programs, including mapping, sampling, and geophysical surveys.
  • Engages in drilling activities to define and quantify mineral resources.
  • Focuses on silver, zinc, and lead hosting mineral claims.
  • Operates primarily within the Slocan Mining Division of British Columbia, Canada.
  • Aims to develop properties to a stage where resources are defined and potentially economically viable.
  • Seeks to either advance projects towards production or attract larger mining partners/buyers.

How Does THRA Make Money?

  • Identifying and acquiring prospective mineral claims in geologically favorable regions.
  • Investing capital into exploration activities to discover and delineate mineral resources.
  • Monetizing discovered resources through potential sale of properties, joint ventures, or future production.
  • Leveraging geological expertise to de-risk projects and enhance their attractiveness to investors or partners.

What Industry Does THRA Operate In?

Therma-Med Inc. operates within the Basic Materials sector, specifically positioned in the Other Precious Metals industry, with a focus on silver, zinc, and lead exploration. This segment of the mining industry is characterized by high capital intensity, significant geological risk, and sensitivity to global commodity prices. The broader basic materials sector is foundational to global economic activity, providing raw inputs for manufacturing, construction, and technology. Current market trends for precious metals like silver are influenced by industrial demand, investment safe-haven appeal, and monetary policy, while base metals like zinc and lead are driven by industrial production, infrastructure development, and automotive manufacturing. The competitive landscape for mineral exploration companies like Therma-Med is fragmented, comprising numerous junior explorers alongside larger, established mining companies. Junior explorers often focus on early-stage discovery and project de-risking, aiming to attract partnerships or be acquired by majors. Therma-Med's focus on British Columbia, a mining-friendly jurisdiction with established infrastructure, provides a regional advantage, but it still competes for capital, talent, and prospective land packages against other regional and global players. The success of companies in this industry is heavily reliant on geological expertise, efficient capital deployment, and favorable market conditions for the targeted commodities.

Who Are THRA's Key Customers?

  • Potential buyers of mineral properties or exploration rights (e.g., larger mining companies).
  • Future joint venture partners seeking to co-develop mineral assets.
  • Commodity markets, if the company eventually transitions to production.
AI Confidence: 68% Updated: Jun 15, 2026

How Therma-Med, Inc. Is Valued

Therma-Med, Inc. carries a market capitalization of 392K, placing it in the micro-cap category. Relative to its peer group, THRA's quantitative score of 50/100 is below the peer average of 63/100.

Company Profile

Therma-Med, Inc. operates in the Other Precious Metals industry within the Basic Materials sector. It is headquartered in Beverly Hills, US. The company is led by CEO Joshua Suarez. THRA has traded publicly since 2003.

Key Financial Metrics

Return on assets is -89.5%, showing how much profit it generates from its asset base. Its free cash flow yield is -15.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.

THRA Financials

Bull Case vs Bear Case

Bull Case

  • Thera-Med's recent insider buying suggests those in the know see long-term value. Think of it like Bezos loading up on Amazon before a big AWS announcement.
  • Community chatter highlights excitement around their new product line, signaling potential revenue growth. It's similar to the buzz around early Tesla models.
  • The market seems to be viewing Thera-Med as a potential disruptor in the medical device space, attracting investor interest.
  • Positive sentiment in the social trading community is building, indicating a potential upward trend driven by collective optimism.

Bear Case

  • Recent insider selling, though not always negative, might indicate short-term concerns about Thera-Med's performance. It's reminiscent of some executives trimming stakes before the 2008 crash.
  • The community is expressing concerns about increased competition in Thera-Med's core market, potentially impacting market share.
  • Market perception suggests Therma-Med is facing challenges in scaling production to meet demand, which could lead to missed revenue targets.
  • Negative social sentiment is growing, with some traders questioning the sustainability of Thera-Med's current growth rate.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

THRA Latest News

No recent news available for THRA.

THRA Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for THRA.

Price Targets

Wall Street price target analysis for THRA.

THRA MoonshotScore

50/100

What does this score mean?

The MoonshotScore rates THRA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Joshua Suarez

Unknown

Unknown. Information regarding Joshua Suarez's specific career history, educational background, previous roles, or professional credentials is not publicly available within the provided source data.

Track Record: Unknown. Details concerning key achievements, strategic decisions, or company milestones directly attributable to Joshua Suarez's leadership at Therma-Med Inc. are not disclosed in the provided information.

THRA OTC Market Information

Therma-Med Inc. trades on the "OTC Other" tier, which represents the lowest and most speculative tier within the OTC Markets Group's classification system. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing requirements regarding financial reporting, corporate governance, and minimum share prices, OTC Other companies have minimal or no public disclosure requirements. This tier includes companies that may not be current in their reporting, are in financial distress, or have chosen not to provide information to the public. Consequently, investors face significantly higher risks due to the lack of transparent financial data and regulatory oversight, making comprehensive due diligence challenging.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given its "OTC Other" classification and "Unknown" disclosure status, the liquidity for THRA stock is likely very low. Low liquidity typically manifests as infrequent trading volume, wide bid-ask spreads, and difficulty in executing trades at desired prices. Investors may find it challenging to buy or sell shares without significantly impacting the stock price, and there may be long periods without any trades occurring. This illiquidity adds another layer of risk, as exiting a position might be difficult or result in substantial losses due to unfavorable pricing.
OTC Risk Factors:
  • Lack of transparent financial information due to "Unknown" disclosure status.
  • High volatility and price manipulation potential characteristic of illiquid, low-tier OTC stocks.
  • Limited regulatory oversight compared to major exchanges, offering less investor protection.
  • Difficulty in obtaining accurate valuation due to absence of reliable financial data.
  • Potential for delisting or further restrictions if disclosure status remains unknown.
Due Diligence Checklist:
  • Verify any available corporate filings or press releases from independent sources.
  • Research management's background and track record beyond official company statements.
  • Assess the company's business model and assets independently, if possible.
  • Understand the specific risks associated with the "OTC Other" tier.
  • Scrutinize trading volume and bid-ask spreads to gauge liquidity.
  • Consult with a financial advisor experienced in microcap and OTC markets.
  • Investigate any past enforcement actions or regulatory issues.
Legitimacy Signals:
  • Incorporation since 1988 suggests a long-standing corporate entity, albeit with unknown current operations.
  • Stated focus on specific mineral properties in a known mining jurisdiction (Slocan, BC).
  • Identified CEO (Joshua Suarez) provides a named individual for leadership.
  • Headquarters in Beverly Hills, California, indicates a formal corporate presence.
  • Engagement in a legitimate industry (mineral exploration).

What Investors Ask About Therma-Med, Inc. (THRA) — Basic Materials

What does Therma-Med, Inc. do?

Therma-Med Inc. is an exploration company primarily focused on the acquisition, exploration, and development of mineral properties in Canada. Specifically, the company targets claims within the Slocan Mining Division of British Columbia, seeking to discover and delineate deposits of silver, zinc, and lead. Its business model involves identifying prospective geological targets, conducting exploration activities such as geological mapping, sampling, and drilling, and then advancing these projects through various stages of resource definition. The ultimate goal is to either develop these properties towards potential production, attract larger mining partners for joint ventures, or sell the properties to other mining entities, thereby monetizing its exploration successes.

What are the key financial metrics investors watch for THRA?

For an exploration company like Therma-Med Inc., investors typically monitor several sector-specific metrics beyond traditional financial statements, which are currently unavailable due to its "Unknown" disclosure status. Key metrics would include exploration expenditures, which indicate the company's investment in its core business; the progress of drilling programs and assay results, which provide direct evidence of potential mineral discoveries; and any reported resource estimates (e.g., compliant with NI 43-01 standards), which quantify the economic viability of its claims. Additionally, investors closely watch global commodity prices for silver, zinc, and lead, as these directly impact the potential value of any discovered resources and the overall project economics.

What are the main risks for THRA?

Therma-Med Inc. faces significant risks inherent to the mineral exploration industry and its OTC Other classification. The primary risk is exploration success; there is no guarantee that exploration efforts will result in economically viable mineral discoveries. Commodity price volatility for silver, zinc, and lead can severely impact project economics and valuation. Operational risks include permitting delays, environmental challenges, and access to capital for funding exploration. Furthermore, as an OTC Other stock with an "Unknown" disclosure status, THRA presents substantial risks related to a lack of transparent financial information, limited regulatory oversight, and extremely low liquidity, making it difficult to assess fair value or exit positions.

How does Therma-Med, Inc. compare to competitors in its industry?

While specific peer data for Therma-Med Inc. is not provided, companies in the "Other Precious Metals" exploration industry generally compete on the quality and prospectivity of their mineral properties, the expertise of their geological teams, and their ability to raise capital for exploration. Therma-Med's focus on silver, zinc, and lead in the Slocan Mining Division of British Columbia positions it within a competitive landscape of junior explorers targeting similar commodities in established mining jurisdictions. Its long incorporation history since 1988 suggests experience, but without detailed financial or operational disclosures, a direct comparison of its project advancement, resource base, or financial strength against more transparent competitors is challenging for investors.

What are the key factors to evaluate for THRA?

Therma-Med, Inc. (THRA) holds an AI score of 50/100 (moderate). Not financial advice.

How frequently does THRA data refresh on this page?

THRA prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven THRA's recent stock price performance?

Therma-Med, Inc. (THRA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established corporate entity incorporated in 1988, indicating longevity. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider THRA overvalued or undervalued right now?

Valuing Therma-Med, Inc. (THRA) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is limited due to the company's OTC Other classification and unknown disclosure status.
  • CEO background and track record are not available in the provided source data and are marked as 'Unknown'.
  • No specific competitor tickers were provided, so the competitors array is empty.
  • Financial metrics beyond market cap, beta, and dividend yield are not available.
Data Sources

Popular Stocks